Skip to main content

ADVERTISEMENT

Andrea Bullock, MD

Andrea Bullock, MD, Harvard Medical School
Videos
08/10/2023
At the 2023 World Congress on Gastrointestinal Cancers, Andrea Bullock, MD, discussed the expanded phase 1 trial of bostensilimab plus balstilimab for heavily pretreated, metastatic microsatellite stable colorectal cancer.
At the 2023 World Congress on Gastrointestinal Cancers, Andrea Bullock, MD, discussed the expanded phase 1 trial of bostensilimab plus balstilimab for heavily pretreated, metastatic microsatellite stable colorectal cancer.
At the 2023 World Congress on...
08/10/2023
Oncology